Veterinary Division (VET) Products
Product List by Brand Name
ITA (NEW) ND
Composition
ITA-NEW (ND) inactivated vaccine contains LaSota strain of Newcastle Disease virus in inactivated form, homogenized with oil adjuvant and merthiolate as a preservative.
Indication
ITA-NEW (ND) inactivated vaccine is recommended for the vaccination of breeder and laying-type chicken flocks, previously immunized against Newcastle Disease (ND) with an attenuated live virus vaccine.
Dosage & Administration
ITA-NEW (ND) inactivated vaccine should be administered to breeder and laying-type chickens 3 to 4 weeks before the onset of lay, between 15 and 20 weeks of age. The vaccine must be injected subcutaneously (under the skin of the neck) or by intramuscular route (breast or thigh muscle) at the dose of 0.5 ml per bird.
ITA ND+IBD
Composition
ITA ND+IBD inactivated vaccine contains a combination of LaSotastrain of Newcastle Disease virus and GP strain of the Infectious Bursal Disease virus in inactivated form, homogenized with oil adjuvant and merthiolate as a preservative.
Indication
ITA ND+IBD inactivated vaccine is recommended for the vaccination of breeder and layer type chicken flocks, previously immunized against Newcastle Disease and Infectious Bursal Disease with attenuated live virus vaccines. Progeny of vaccinates will have specific maternal antibodies against ND and IBD.
Dosage & Administration
ITA ND+IBD inactivated vaccine should be administered to breeder an d layer-type chickens 3 to 4 weeks before the onset of lay, between 15 and 20 weeks of age. The vaccine must be injected subcutaneously (under the skin of the neck) or by intramuscular route (breast or thigh muscle) at the dose of 0.5 ml per bird.
ITA ND+IB+EDS+Coryza ABC
Composition
ITA ND+IB+EDS+COR ABC inactivated vaccine contains a combination of LaSota strain of Newcastle Disease virus, Massachusetts strain of the Infectious Bronchitis virus, B8/78 strain of the EDS virus and the serotypes A, B and C of the Avibacterium paragallinarum bacteria in inactivated form, homogenized with oil adjuvant and merthiolate as a preservative.
Indication
ITA ND+IB+EDS+COR ABC inactivated vaccine is recommended for the vaccination of breeder and laying type chicken flocks, previously immunize d against Newcastle Disease, Infectious Bronchitis, and infectious coryza.
Dosage & Administration:
ITA ND+IB+EDS+COR ABC inactivated vaccine should be administered to breeder and laying-type pullets, 2 to 4 weeks before the onset of lay, between 14 and 18 weeks of age. The vaccine must be injected subcutaneously (under the skin of the neck) or b y intramuscular route (breast or thigh muscle) at the dose of 0.5 ml per bird.
ITA ND+IB+EDS
Composition:
ITA ND+IB+EDS inactivated vaccine contains a combination of LaSota strain of Newcastle Disease virus, the Massachusetts strain of the Infectious Bronchitis virus and B8/78 strain of the EDS virus in inactivated form, homogenized with oil adjuvant and merthiolateas a preservative.
Indication:
ITA ND+IB+EDS inactivated vaccine is recommended for the vaccination of breeder and laying -type chicken flocks, previously immunized against Infectious Bronchitis and Newcastle Disease with attenuated live virus vaccines.
Dosage & Administration:
ITA ND+IB+EDS inactivated vaccine should be administered to breeder and laying -type pullets 3 to 4 weeks before the onset of lay, between 15 and 20 weeks of age. The vaccine must be injected subcutaneously (under the skin of the neck) or by intramuscular route (breast or thigh muscle) at the dose of 0.5 ml per bird.
ITA Coryza ABC Gel
Composition:
ITA CORYZA ABC Gel inactivated vaccine contains a combination of Avibacterium paragallinarum, serotypes A, B and C, homogenized with aluminium hydroxide adjuvant and merthiolate as a preservative.
Indication:
ITA CORYZA ABC Gel inactivated vaccine is recommended for the vaccination of breeder and layer type chicken flocks, against infectious coryza caused by Avibacterium paragallinarum.
Dosage & Administration:
ITA CORYZA ABC Gel inactivated vaccine should be administered to breeder and layer -type chickens between 8 and 12 weeks of age. The vaccine must be injected subcutaneously (under the skin of the neck) or by intramuscular route (breast or thigh muscle) at the dose of 0.5 ml per bird. The program should be completed 4 to 6 weeks later, using an inactivated oil-adjuvant vaccine against infectious coryza.
Itracon
Composition
Itracon SUBA Capsule: Each capsule contains Itraconazole USP 65 mg.
Itracon 100 Capsule: Each capsule contains Itraconazole pellets equivalent to Itraconazole USP 100 mg.
Itracon 200 Tablet: Each film coated tablet contains Itraconazole USP 200 mg.
Itracon Oral Solution: Each 5 ml oral solution contains Itraconazole USP 50 mg.
Indications
Itracon Capsule & Tablet : Tinea corporis, Tinea cruris, Tinea pedis, Tinea manuum, Vulvovaginal candidiasis, Fungal keratitis, Pityriasis versicolor, Oropharyngeal candidiasis, Onychomycosis, Histoplasmosis, Systemic Infections: Aspergillosis, Candidiasis and Cryptococcal infection when other drugs are ineffective. Antifungal prophylaxis: To prevent systemic fungal infection in severely neutropenic patients.
Itracon Oral Solution: It is indicated for the treatment of Oropharyngeal Candidiasis & Esophageal Candidiasis.
Dosage & Administration
Itracon SUBA: 65 mg twice daily for all type of fungal infections.
Itracon Tablet & Capsule:
Tinea corporis, Tinea cruris: 100 mg daily for 2 weeks; Tinea pedis, Tinea manuum: 100 mg daily for 4 weeks; Vulvovaginal candidiasis: 200 mg twice daily for 1 day; Fungal keratitis: 200 mg daily for 3 weeks; Pityriasis versicolor: 200 mg daily for 1 week; Oropharyngeal candidiasis: 100 mg daily (200 mg for immuno compromised patients) for 15 days; Onychomycosis: 200 mg daily for 3 months; or 200 mg twice daily for 7 days (course), subsequent courses to be repeated after 21 days interval; fingernails 2 courses and toenails 3 courses; Histoplasmosis: 200 mg 1-2 times daily; Systemic Infections: 200 mg once daily (Aspergillosis, Candidiasis and Cryptococcus infection when other drugs are ineffective), increased in invasive or in cryptococcal meningitis to 200 mg twice daily;
Antifungal prophylaxis: To prevent systemic fungal infection in severely neutropenic patients 100 mg daily.
Itracon Oral Solution: This solution should be vigorously swished in the mouth (10 ml at a time) for several seconds and swallowed. The recommended dosage of Itracon oral solution for Oropharyngeal Candidiasis is 200 mg (20 ml) daily for 1 to 2 weeks. The recommended dosage of Itracon oral solution for Esophageal Candidiasis is 100 mg (10 ml) daily for a minimum treatment of 3 weeks. Child Dose: 5 mg / kg once daily for 14 days. For oral use only (for 1 month to 11 years of age) Should be taken after meal or as directed by the physician.
